Dr. Koeberl attended Carleton College, and then Mayo Medical School and Graduate School, before moving to UCSF for his pediatrics residency. He then completed fellowship training in Clinical and Biochemical Genetics at the University of Washington, before joining the Division of Medical Genetics in the Department of Pediatrics at Duke University in 1999. He serves as Medical Director for the Pediatrics Biochemical Genetics Laboratory and sees patients in the Metabolic Clinic. His research has focused on the development of new therapy for inherited metabolic disorders, including glycogen storage disease type Ia and Pompe disease. He initiated a clinical trial of AAV8 gene therapy for Pompe disease that is ongoing. His laboratory is currently developing genetic therapies for trifunctional protein deficiency and LCHAD deficiency.
